- Report
- August 2025
- 195 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 192 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
Sulfadimidine is an antibiotic used to treat bacterial infections. It belongs to a class of antibiotics known as sulfonamides, which are used to treat a wide range of infections. Sulfadimidine is used to treat urinary tract infections, skin infections, and respiratory infections. It is also used to prevent infections in people who are at risk of developing them. Sulfadimidine is available in both oral and injectable forms. It is generally well tolerated, but can cause side effects such as nausea, vomiting, and diarrhea.
The sulfadimidine market is a competitive one, with several companies offering products. Some of the major players in the market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Novartis. These companies offer a range of products, including tablets, capsules, and injections. Other companies in the market include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more